Table Of Content

Subject index Key: c = correspondence, e = editorial, 1 review A radiocontrast-mediated 546c B Abdominal pressure right-to-left interatrial shunt, prone posi Bicarbonate in the critically ill 1453 tion 412 continuous hemofiltration 1211 e, Acidosis secondary to thermal injury 1231 1244 inion ¢ ap after HES administration severity, outcome, and current definition hypercapnia 425c, reply 425c 1287 930 Bilevel positive airway pressure (BIPAP) continuous hemofiltration 1244 surfactant 330c and APRV 1203e Acute Physiology and Chronic Health volume-dependent compliance 1084 in pediatric practice 1194 Evaluation (APACHE) (see Scores) Yersinia enterocolitica sepsis 226, 1340c non-invasive 458 Acute lung injury (ALI) reply 1341¢c patient-ventilator synchrony 645e endothelial-specific proteins 1259 Acute respiratory failure (ARF) Book review 329, 1197, 1330, 1467, 1467 epidemiological data challenge 884e cardiogenic pulmonary edema Botulism inhaled nitric xide 88le noninvasive ventilation 662 cranial nerve palsies and descending pa- inhaled nitric oxide European multi partial liquid ventilation combined with ralysis 765c centre study 911 kinetic therapy 496 Bronchodilators pertussis 1346¢ prognosis and cost-utility analysis in airway obstruction due to tracheomala- physiology and P-V curve 1040e COPD 452 cla "729 prevalence, etiology, outcome 920 Adhesion molecules COPD 1206e prone position 1222 human albumin 11235577 e, 1381 influence of tidal volume 1215 severity, outcome and, current definition Alcohol in the ICU 230 >) agitation 852 Bronchopleural fistula volume-dependent compliance 1084 detection in saliva 492 selective bronchial blockade using a Fo- Acute phase proteins Alkalosis garty catheter 535 ifter cardiac arrest 1386 anionic bases in renal replacement ther- Brain death Acute respiratory distress syndrome apy 1209e energy expenditure 970 (ARDS) treatment with omeprazole 1201 c transcranial Doppler ultrasonography abdominal computed tomography 330c Allergy Q99 ifter pneumonectomy 1173 hydroxyethyl starch 22 20 c ulveolar recruitment 1297 Alveolar recruitment intioxidant status 134e, 180 sustained inflation in ARDS 1297 ‘1-esterase inhibitor APRV/BIPAP 1203e Analgesics graft failure after lung transplantation beta thalassemia and yersiniosis in Danish ICUs 186 1315 bronchodilators 230 Antioxidant status hereditary angioedema and inhald adre- consensus on ventilator—associated lung ARDS 134e, 180 naline 1337c¢ injury 1444 N-acetyl cysteine 432e ardiac output corticosteroids 1191 Aspiration bronchial thermodilution 211 epidemiological data challenge 884e nasojejunal tube feeding 574 continuous monitoring 13le epidemiology and outcome 538 scintigraphic evaluation 311 continuous thermodilution 166 ethylene glycol intoxication 1200c ventilator-associated pneumonia 553e ‘apgras delusion fluvoxamine overdose 548¢ Asthma following critical illness 1183 following bilateral femoral nailing 547c anaphylactoid reaction to hydroxyethyl apillary leak functional residual capacity 540 starch 220 Clark’s syndrome 334c hemodynamic profile 246c hypercapnia 425c, reply 425c indocyanine and glucose dilution hypersensitivity pneumonitis Atrial tachyarrhythmia method 304 improved outcome 887e after cardiac surgery 242c, reply 243c ardiac arrest improved prognosis 936 pulsus paradoxus indicating heart fail- acute phase response 1386 inhaled nitric oxide 88le ure 333c soluble L- and P-selectins 588 nhaled nitric oxide modulator of lung role of magnesium infusion 243c, reply ardiac troponin I injury 1024 243¢c fluid therapy 625 inhaled nitric oxide in combination with Auditory evoked potentials sepsis 1165 iv prostacyclin 752 1474¢, reply 1475c electrophysiological monitoring in IC Cardiogenic shock (see heart failure) intrahepatic porto-systemic shunt 1333c 350e Cardiopulmonary bypass malaria 744 sedation scores 377 metabolic acidosis necessity of transesophageal echocardio- Automatic tube compensation ‘ardiopulmonary resuscitation pargtiraalp hyl iqu6i3d 7¢v entilation 42~0 worokm y of tubbreesa th5i1n4g imposed by tracheost- actliivvee r croumppteusres ion10-3d2ecc ompression post-traumatic stress disorder 697 Autopsy soluble L- and P-selectins 588 prevalence, etiology, outcome 920 quality assurance inICU 360 Cefpirome prone position and nitric oxide 29 tooi to monitor diagnostic error 343e in posttraumatic SIRS 486 Subject index Key: c = correspondence, e = editorial, 1 review A radiocontrast-mediated 546c B Abdominal pressure right-to-left interatrial shunt, prone posi Bicarbonate in the critically ill 1453 tion 412 continuous hemofiltration 1211 e, Acidosis secondary to thermal injury 1231 1244 inion ¢ ap after HES administration severity, outcome, and current definition hypercapnia 425c, reply 425c 1287 930 Bilevel positive airway pressure (BIPAP) continuous hemofiltration 1244 surfactant 330c and APRV 1203e Acute Physiology and Chronic Health volume-dependent compliance 1084 in pediatric practice 1194 Evaluation (APACHE) (see Scores) Yersinia enterocolitica sepsis 226, 1340c non-invasive 458 Acute lung injury (ALI) reply 1341¢c patient-ventilator synchrony 645e endothelial-specific proteins 1259 Acute respiratory failure (ARF) Book review 329, 1197, 1330, 1467, 1467 epidemiological data challenge 884e cardiogenic pulmonary edema Botulism inhaled nitric xide 88le noninvasive ventilation 662 cranial nerve palsies and descending pa- inhaled nitric oxide European multi partial liquid ventilation combined with ralysis 765c centre study 911 kinetic therapy 496 Bronchodilators pertussis 1346¢ prognosis and cost-utility analysis in airway obstruction due to tracheomala- physiology and P-V curve 1040e COPD 452 cla "729 prevalence, etiology, outcome 920 Adhesion molecules COPD 1206e prone position 1222 human albumin 11235577 e, 1381 influence of tidal volume 1215 severity, outcome and, current definition Alcohol in the ICU 230 >) agitation 852 Bronchopleural fistula volume-dependent compliance 1084 detection in saliva 492 selective bronchial blockade using a Fo- Acute phase proteins Alkalosis garty catheter 535 ifter cardiac arrest 1386 anionic bases in renal replacement ther- Brain death Acute respiratory distress syndrome apy 1209e energy expenditure 970 (ARDS) treatment with omeprazole 1201 c transcranial Doppler ultrasonography abdominal computed tomography 330c Allergy Q99 ifter pneumonectomy 1173 hydroxyethyl starch 22 20 c ulveolar recruitment 1297 Alveolar recruitment intioxidant status 134e, 180 sustained inflation in ARDS 1297 ‘1-esterase inhibitor APRV/BIPAP 1203e Analgesics graft failure after lung transplantation beta thalassemia and yersiniosis in Danish ICUs 186 1315 bronchodilators 230 Antioxidant status hereditary angioedema and inhald adre- consensus on ventilator—associated lung ARDS 134e, 180 naline 1337c¢ injury 1444 N-acetyl cysteine 432e ardiac output corticosteroids 1191 Aspiration bronchial thermodilution 211 epidemiological data challenge 884e nasojejunal tube feeding 574 continuous monitoring 13le epidemiology and outcome 538 scintigraphic evaluation 311 continuous thermodilution 166 ethylene glycol intoxication 1200c ventilator-associated pneumonia 553e ‘apgras delusion fluvoxamine overdose 548¢ Asthma following critical illness 1183 following bilateral femoral nailing 547c anaphylactoid reaction to hydroxyethyl apillary leak functional residual capacity 540 starch 220 Clark’s syndrome 334c hemodynamic profile 246c hypercapnia 425c, reply 425c indocyanine and glucose dilution hypersensitivity pneumonitis Atrial tachyarrhythmia method 304 improved outcome 887e after cardiac surgery 242c, reply 243c ardiac arrest improved prognosis 936 pulsus paradoxus indicating heart fail- acute phase response 1386 inhaled nitric oxide 88le ure 333c soluble L- and P-selectins 588 nhaled nitric oxide modulator of lung role of magnesium infusion 243c, reply ardiac troponin I injury 1024 243¢c fluid therapy 625 inhaled nitric oxide in combination with Auditory evoked potentials sepsis 1165 iv prostacyclin 752 1474¢, reply 1475c electrophysiological monitoring in IC Cardiogenic shock (see heart failure) intrahepatic porto-systemic shunt 1333c 350e Cardiopulmonary bypass malaria 744 sedation scores 377 metabolic acidosis necessity of transesophageal echocardio- Automatic tube compensation ‘ardiopulmonary resuscitation pargtiraalp hyl iqu6i3d 7¢v entilation 42~0 worokm y of tubbreesa th5i1n4g imposed by tracheost- actliivvee r croumppteusres ion10-3d2ecc ompression post-traumatic stress disorder 697 Autopsy soluble L- and P-selectins 588 prevalence, etiology, outcome 920 quality assurance inICU 360 Cefpirome prone position and nitric oxide 29 tooi to monitor diagnostic error 343e in posttraumatic SIRS 486 pharmacokinetics during hemofiltration prevention of chronic lungs disease high End of life decisions 1427 risk preterm infants 712 in intensive care 893e Central venous catheter sepsis 556e withdrawal of life support 949 lethal complication 1180 toxic epidermal necrolysis 1307 Endocarditis liver disease and coagulopathy 481 Costs ARDS 637c Central venous pressure antibiotics in ICU 1407 methicillin-resistant S. aureus 236c cardiac output, oxygen consumption and errors in medication administration Endotoxin delivery, 126c, repiy 126c 341e core anitbodies 427e Cerebral blood flow human albumin administration in criti heat shock protein 70 expression 52 decompressive craniectomy 1327 cally ill patients 323 reduction of half-life after vitamin A endothelin-1 1282 intensive care 345e 1160 Cerebral perfusion pressure manpower in ICU 606 Endotoxin core anitbodies cerebrospinal fluid gas tensions 599 mechanical ventilation and COPD editorial 427e early jugular bulb oxymetry in severe 452 mortality in sepsis syndrome 435 brain trauma 445, 1476c, reply 1476c Omega system 245c, reply 246c vitamin A 1160 endothelin-1 1282 organizational changes in ICU 1367 Epidemiology jugular bulb oxymetry 430e selective decontamination of the diges ARDS 538 Lund therapy 244c tive tract (SDD) 1323 community-acquired pneumococcal management and results 3 "71 i in critically ill patients 1323 pneumonia 198 outcome after severe head injury 348¢ upper gastrintestinal hemorrhage 364 feverinICU 668 vasogenic oedema 244c, reply 244c¢ C-reactive protein Erythropoietin Cervical necrotizing fasciitis after cardiac arrest and hypoxia 1386 ifter cardicac arrest and hypoxia 1386 series of 20 patients 829 head injury in children 288 Ethics Chronic obstructive pulmonary disease Critical illness neuromuscular abnormality end of life decisions 893e (COPD) (CINMA) withdrawal of life support 949 bronchodilators 230, 233, 1206e, 1215 hyperosmolar non-ketotic coma 1347 European Society of Intensive Care Medi community-acquired pneumococcal repiratory failure after ICU discharge cine (ESICM) pneumonia 198 1302 intra-hospital transport of head injured intrinsic PEEP 252e, 1215 sepsis 641 c, reply 642c patients 1441 lung volume reduction 1319 Cytokines management of nutrition in European mechanical ventilation 1206e abdominal aortic aneurysm repait intensive care units 95 mechanical ventilation: prognosis and 279 Evidence based medicine cost-utility analysis 452 cardiac arrest and CPR 588 management of acute necrotising pan non-invasive ventilation 1e, 423c, reply heat stroke 315 creatitis 146 424¢ immunmodulatory therapies in sepsis Extracorporeal membrane oxygenation proportional assist ventilation 1021 556e after cardiac surgery in children 543 proportional assist vs. pressure support in major surgery 255e lung transplantation 1315 ventilation 790 inhibition by phosphodiesterase inhibi- outcome in ARDS 887e Coagulopathy tors 620 radiocontrast-mediated ARDS 546 administration of prothrombin complex removal by renal replacement therapies Extravascular lung water 1105 9091 double vs. single indicator dilution tech central venous catheterisation 481] thyroid function 1402 nique 216 hirudin during hemofiltration ]1 31 l whole body hyperthermia |1 013 whole body hyperthermia 959 Coma barbiturates in cerebral vasospasm D F 406 D-dimer Fever electrophysiological monitoring predictor of mortality 207 epidemiology in ICU 668 hyperosmolar non-ketotic 347 Dobutamine in intensive care 648e malaria 744 systemic and regional effects ins septic Fibrinolysis sound-musical stimulation 422¢ shock 942 after subarachnoid hemorrhage 1463 Continuous positive airway pressure Dopamine pericarditis 338¢ (CPAP) renal effects in head injury 399 Functional residual capacity cardiogenic pulmonary edema le Dopexamine measurement 540 noninvasivei n non-COPD-patients 1374 systemic and regional effeincs tsespti c measurement in mechanically ventilated work of breathing imposed by tracheost shock 942 infants 1118 omy tubes 514 Drug abuse Corticosteroids panarteritis 113 G ARDS 1191 Dynamic pulmonary hyperinflation gastric intramucosal pH cardiac tamponade in Kawasaki disease relevance of intrinsic PEEP measure alveolar ventilation 269 1137 ment 252e assessment of regional tissue oxygena dexamethasone in bacterial meningitis tion 10441 475 E effect of dobutamine and dopexamine herpetic hepatitis 415 Electroencephalography 942 hypopituitarism and circulatory shock brain death 82>2 influencing factors 249e 865 severe head injury 872 N-acetylcysteine in septic shock 432¢ vancomycin assay 129] electromagnetic fields 843 now ty ment by metoclopramid vancomycin clearance 1100 end of life decisions 893e 343 ¢ Hepatic failure errors in medication administration renal failure 51 341 e. 353 Hepatitis fever 64e.8 6 68 C- cryoglobulinemia and alveolar h health system research 1353e brospinal fluid gas tensions morrhage 319 hematological patients 1395 . ompressive craniectomy 13 herpetic — following corticotherapy infectious disease consultation 1010 jugular bulb oxymetry 445 415 management of nutrition in European 1476¢ High frequency oscillatory ventilation intensive care units 95 ncephalography 872 ARDS after pneumonectomy 1173 managing expectations 550c improvement of outcome determination of airway humidification medical activity and Omega system nduced hypertension 1006 997 245c. reply 246¢ nterleukin-6 and C-reacti in children 1194, 1459 molecular biology 65 2e tal transport open lung concept 990 monitoring alarms 1350e uulb oxymetry 430 Human albumin need of intermediate care units 1345e nt and results idministration in critically ill patients organizational changes and cost-effec 27 3, 1033, reply 1033c tiveness 1367 yurden in multidi cardiac troponin I 625 post Iclt mortality 1035e. 106 endothelial cell adhesion molecules sedation 137e fect of dopamin 1381 sedatives, analgesics and neuromuscula! osensorvyv evoked pote! heterogeneity of preparations blocking agents 186 Hydroxyethyl starch stressors 142] anaphylactoid reaction 220, 767c, reply withdrawal of life support 949 06/C Interleukines anion gap 1287 abdominal aortic aneurysin repail syndrome 334c cardiac troponin I 625 ?79 ypropoxyphene-induce international view 258r 1344¢, reply after major surgery 255e nical Cardiac assistancc +5 1345¢ cardiac arrest and CPR 588 n7 ical venr til]a tion in conjunc) tio’ n renal effects 1344¢ head injury in children 288 th intra-aortic balloon pump 83 Hypercapnia immunmodulatory therapies in sepsis | ventilation with bicarbonate buffering Oe Hyperthermia Intermediate care units fever in ICI 648 e pro and contra 1345c S paradoxus and sup! hemorrhagic shock and encephalopathy Intoxication ivcardia 333¢ syndrome 293 causing agitation 852 i moisture exchanger (HMI preconditioning in rat peritonitis 1155 ecstasy 640c ical and microbiological whole body ether 337c, reply 338c multiple organ dysfunction 1013 ethylene glycol 859, 1200c secure procedure ? 959 fluvoxamine 548c simple complexities 898 ¢ intrathecal baclofen-overdose 239¢c Hypopituitarism methamphetamine 758 circulatory shock 865 methanol 528 } purilication therapy Hypothermia orphenadrine 1134 xide production SR induced in asphyxiated newborns propanolol 336c He modialysis/hemofiltration rewarming strategy 520 verapamil 1473c ited clotting time using Hypothyroidism Intra-aortic balloon pump j cytokines 1402 and mechanical ventilation 835 bases 1209¢ procalcitonin after trauma 1031 c dextropropoxyphene-induced cardio pirome pharmacokinetics genic shock 335c ite In posttraumatl I mechanical cardiac asistance 543 Immunonutrition postpartum heart failure 223 in the critically ill 63 Intracerebral hemorrhage Indocyanine green incidence in critically ill patients 63 plasma volume measurement 12 Intracranial pressure 1252 book review 329 Intensive Care cerebrospinal fluid gas tensions 599 acute renal failure 1188 decompressive craniectomy 1327 care unit 7811 admission patterns and outcome in South early jugular bulb oxymetry in severe earance and remova African paediatric ICU 88 brain trauma 445, 1476c, reply 1476c autopsy to monitor diagnostic error endothelin-1 1282 343e . 360 jugular bulb oxymetry 430e nin clearance dermatological disorders 1271 management and results 371 766¢ reply ' il of cvtokines discharge decision making 1035e 766¢ use of different buffers early enteral feeding 129e outcome after severe head injury 348e permissiv1e9 6 hypercapnia and PEEP 125 COPD 1206¢ early enteral fe:e ding 129e reply 125c exhalation valve and respiratory m heat stroke 315 Intrathoracic blood volume chanics 799 intermittent high-volume hemofiltration double vs. single indicator dilution tech functional residual capacity 540 814 nique 216 heat and moisture exchanger (HME) multiple injury and early enteral feeding Inverse ratio ventilation (IRV) 1237 129¢ variability of arterial oxygenation 37 ICU nosocomial infection risk 567 renal replacement therapy after trauma inspiratory flow waveform 503 805 J intracerebral hemorrhage in critically ill SOFA: prospective. multicenter study Jugular venous oxymetry patients 63 686 cerebrospinal fluid gas tensions 599 intrinsic PEEP measurement 252¢ SOFA score in trauma 389 early monitoringi n severe brain trauma maintainig spontanes whole body hyperthermia 445, 1476c, reply 1476¢ 12 Myoglobin induced hypertension after head injury model for extubation bacterial sepsis-induced rhabdom) 1006 lasojel il tube feeding } 469 management of severe head injury 3 open lung concept clearance and removal during hen severe head injury 430¢ respiratory model for prediction of pa tration 1169 tients’ respon pressure-volu therapy prognosis and co itilits lalysis in N-acetyl cysteine in combination with partliiquiad lven ti COPD 452 antioxidant therap lation 496 proportional assist itilati , in the criticlly ill sedation 634 NADH fluorescence therapy for failing heart issessofm reeginontal t thoracentesis 896 tion 10441 icidosis during cardiopulmonary bypass small tidal volumes 771 Near-infraread specti 680) upper gastrointestinal bleeding 11 issessment OI region inalyzer 508 variabilityo f arterial oxygenation 3 tion 10441 assessmofe tnistsu e oxygenation 10441 ventilator ocia yneumonia 553 Neutropenia continuous hemofiltration 1244 inflammation hematopoietic hand-held analyzer 966 } tors 1003 metabolic marker in critically ill} hematopoietic growt! 890 e Neurofibromatosis Laryngeal mask diaphragm paralysis laryngotracheo-oesophagea 7 ethicillin-resistant wreus (MRSA) Neuromuscular blockade routine, risk,o r rescue 76] I 23 in Danish ICUs 186 Lidocaine ethylpyrazole Neuromuscular disord pharmacokinetics in critcally p nt methanol poisoning 5: in ICU 641 110 etoclopramide Nicardipine Liver failure improvement ¢ istric emptyin 4 hypertension in central venous cannulation 481 1342c¢, reply 1343; Nitric oxidIeC (NO) herpes simplex 415 olecular biology ARDS and ALI &81e intracerebral hemorrhage in critically il for the ir ISIVISt ARDS and prone position patients 63 impact on intensi ire medicine 65 European multicentre st intrahepatic porto-systemic shunt and onitoring heat stroke 58 ARDS 1333¢c ilarms and pa fety improvement mitral regurgitation 1131] alarmsi n | 360) mole 300 renal failure 51 issessmel n combination Liver transplantation tion 10441 ic, reply impon arencal tfail ure 5r bronchial the inhaled nitric oxide in combina pulmonary hypertension treated with continuous cardiac output |3le, 166 1erosolized prostacyclin NO 638c gastric intramucosal pH and alveola lung transplantation 1315 respiratory burst 6 12 ventilation changes 269 modulofa ltungo inrju ry tirilazad mesylate as antioxidant 616 influencing fa of gastro 5 outcome in ARDS 8&87e Ate Lund therapy nometry pulmonary hypertension after liver severe head injury 371 plasma volume transplantation 638c pulmonary artery ' terial thert rebound pulmonary hypertension 76 M lution 843 respiratory mechanics in RSV bronchio Malaria Morphine litis 81 management inICU 744 pharmacokinetics in cri venous air embolism 983 Mechanical ventilation Multiple myeloma Noninvasive ventilation aspiration 311 prognosis and outcome in ICl | acute respiratory failure aspirationo f dead space 674 Multiple organ failure (MOF) bronchodilators 230 bronchodilators 230, 233, 1206¢ cholesterol 748 cardiogenic pulmonary edema comparison of different modalities 775 D-dimer 207 COPD experience at a community teaching Bronchopulmonary dysplasia intracranial pressure 125c, reply 125c hospital 458 prediction 241 c, reply 241 c outcome in ARDS 887e expiratory trigger 662 Chronic lung disease Pharmacokinetics in non-COPD patients 1374 early postnatal dexamethasone in high cefpirome during hemofiltration 1427 patient-ventilator synchrony 645¢ risk preterm infants 712 cefpirome in posttraumatic SIRS 486 prevention of ventilator-associated Dead space morphine and lidocaine in critcally pa- pneumonia 553<¢ measurement in newborns 705 tients 110 reducing ICU nosocomial inf Functional residual capacity vancomycin clearance during hemofil- S67 measurement 1118 tration 1100 role in ICU 423c, reply 424« Head injury Pheochromocytoma weaning from mechanical ventilation somatosensory evoked potentials 722 isolated quadriparesis 123c Se Hemorrhagic shock and encephalopathy Phosphodiesterase inhibitors Nutrition syndrome in SIRS/sepsis and congestive heart fail- intioxidant status in ARDS neurological course and predictors of ure 620 early enteral feeding 129¢ outcome 293 Plasma volume fat emulsions and platelet membrane li High frequency oscillatory ventilation indocyanine green 1252 pids 3045 efficacy and safety 1459 measurement 1212e gastrojejunal tubes 162 new insights 1194 Platelets immunonutrition 63] vs. conventional mechanical ventila- central venous catheterisation 48] in European intensive care units 95 tion 68, 1459 fat emulsions 395 intestinal permeability and multiple or Intensive Care Pneumonia gan failure after trauma 157 admission pattcrns and outcome in bronchopleural fistula 535 nasojejunal tube feeding 574 South African paediatric ICU 88 community-acquired pneumococcal Laryngeal mask 143e, 198 oO laryngotracheo-oesophageal clefts 714 diaphragm paralysis due to neurofibro- Omeprazole Laryngotracheo-oesophageal clefts matosis 1338c¢ metabolic alkalosis laryngeal mask 714 Legionella pneumophila imipenem Outcome Mechanical ventilation 1030 ifter intermittent high-volume hemofil- dead space measurement 705 neutrophil exocytosis 44 tration 814 high frequency oscillatory ventilation prophylaxis of upper gastrointestinal ARDS 538. 881e. 920. 930 63 bleeding 118 head injury in children 722 new insights 1194 toxic shock syndrome 4 Sc health system research 1353¢ Neonates ventilator-associated hemorrhagic shock and encephalopathy early postnatal dexamethasone in high avoidance of tracheal intubation 553¢e syndrome 293 risk preterm infants 712 endotracheal tube biofilm 1072 organizational changes in ICI laryngotracheo-oesophageal clefts and Pneumothorax SOFA score 686 laryngeal mask 714 after removal of a feeding tube 331c weaning from mechanical ventilation respiratory distress syndrome 68 ultrasound diagnosis 383 OI severe tracheomalacia 729 Polymorphonuclear neutrophils (PMN) Oxygen consumption Nitric oxide ARDS 134e central venous pressure and cardiac out improvement of response after dypri- pneumonia 44 put 126c, reply 126c damole 300 respiratory burst after liver transplanta- Oxygen delivery pulmonary vasospasm or vascular ob- tion 612 central venous pressure and cardiac out- struction 1126 Positive end-expiratory pressure (PEEP) put 126c, reply 126c respiratory mechanics in RSV bron- consensus on ventilator—associated lung Oxygen electrodes chiolitis 81 injury 1444 assessment of regional tissue oxygena- rebound pulmonary hypertension 76 effect on intracranial pressure 125c, re- tion 10441 Pulmonary hypertension ply 125c differentiation with inhaled NO 1126 intrinsic P rebound during weaning off nitric bronchodilators in COPD 1206e Palladium-porphyrin-phosphorescence oxide 76 1215 issessment of regional tissue oxygena Respiratory distress syndrome dynamic, static 274, 768c, reply 769c tion 10441 conventional mechanical ventilation proportional assist vs. pressure sup- Panarteritis vs. high frequency oscillatory venti- port ventilation in COPD 790 drug abuse 11 lation 68 relevance of measurement 252e Pancreatitis Surfactant protection against lung collapse in evidence-based magement respiratory distress syndrome 68 pigs 1140 Partial liquid ventilation Pericardial effusion stenting effect in severe tracheomala- combinde with kinetic therapy 496 in association with gastroschisis 422c cia 729 review 420 Pericarditis therapy for failing hearts 778e Pediatric and neonatal intensive care cardiac tamponade in Kawasaki disease variability of arterial oxygenation 37 Brain asphyxia 1137 Postpartum induced hypothermia 11 fibrinolysis 338c cerebral vasospasm 532 Bronchodilators Permissive hypercapnia heart failure 223 severe tracheomalacia 729 in infants 1194 nicardipine 1277 Post-traumatic stress disorder Pulmonary hypertension Mortality Probability model (MPM) II after intensive care treatmetn for ARDS inhaled nitric oxide in combination with Y 697 aerosolized prostacyclin 1147 nine equivalents of nursing manpowert Pre-eclampsia inhaled nitric oxide in combination with use score (NEMS) 606 nicardipine 1277 iv prostacyclin 752, 1474c, reply 1475c Omega system 245c, reply 246c Pressure support ventilation pertussis 1346¢ SAPS II prognostic performance cardiogenic pulmonary edema le, 21 pulmonary vascular reactivity 1413 and customization 192, 878c, reply different modalities of mechanical venti venous air embolism and inhaled j NO 879¢ lation 775e OR3 sedation 377 noninvasive in non-COPD-patients Pyelonephritis SOFA score in trauma 389 1374 gas-forming E. coli 628 SOFA: prospective, multicenter study versus proportional assist ventilation in 636 COPD 790 Q TISS-28 606 work of breathing imposed by tracheost Quality assurance TISS and post ICU mortality 1035¢ omy tubes 514 application of mortality prediction sys 1061 Procalcitonin tems 977 Scintigraphy after trauma in a thyroidectomized pa autopsy 343 e. 360 evaluation of aspiration 311 tient 1031c medication errors 341 e, 353, 1478¢ Sedation clearance during hemofiltration 1198 scoring systems inICU 418 auditory evoked potentials 377 Prognosis clorazepam for alcohol withdrawal syn abdominal CT and ARDS 330c R drome 1435 community-acquired pneumococcal Ranitidine electrophysiological monitoring 350¢ pneumonia 198 upper gastrointestinal bleeding during in Danish ICUs 186 electroencephalography in head injury mechanical ventilation 118 in intensive care 137e. 634 979 Regional tissue oxygenation Selective decontamination of the digesti' endotoxin-core antibodies in sepsis assessment 1044 tract (SDD) 435 Renal failure in critically ill patients 1323 mechanical ventilation and COPD 452 ifter acyclovir treatment 639¢ psis (sec also septic shock and SIRS) multpile myeloma in ICU 1395 in critically ill 1188 cholesterol 748 SAPS II 192 intermittent high-volume hemofiltration critical illness neuromuscular abnormal somatosensory evoked potentials in head R14 ity 641 c, reply 642c injury in children 722 intracerebral hemorrhage in critically ill endotoxin and heat shock protein ex Prone position patients 63 pression 52 ilveolar recruitment in ALI liver disease Sr endotoxin-core anitbodies 427 ARDS and NO 29 myoglobin clearance and removal during euthyroid sick syndrome 1402 prevention of ventilator—associated lung hemofiltration 1169 improvement of cardiovascular function injury 1444 renal replacement therapy inICU 78le with hemofialtration 733 spotaneous breathing after near-drown early vs.late renal replacement afte immune response 1027 ing 1469¢c trauma 805 immunglobulins 427¢ € Proportional assist ventilation rhabdomyolysis 469 immunmodulatory therapies in sepsis current topic 1021 Vancomycin assay SS6e different modalities of mechanical venti Respiratory burst intermittent high-volume hemofiltration lation 77S5e increased by GM-CSF after liver trans 814 versus pressure support ventilation in plantation 612 mortality and endotoxin-core antibodies COPD 790 Respiratory mechanics 435 Prostacyclin effects of open heart surgery 1092 milrinone for cardiac output increase hypoxic pulmonary hypertension 1147 FRC measurement in mechanically ven 620 in combination with inhaled nitric oxide tilated infants 1118 phosphodiesterase inhibitors 620 752, 1474c, reply 1475c lung collapse in pigs prevention and treatment 869 Prothrombin complex nitric oxide 81 rhabdomyolysis 469 emergency correction of coagulation prone position in ARDS 1222 I helper cell subset ratios 106 1131 Rhabdomyolysis toxic epidermal necrolysis 1307 influence on plasma coagulation in criti bacterial sepsis-induced 469 troponin and myocardial injury cally ill patients 1105 1165 Pulmonary artery catheter S Yersinia enterocolitica in patient with continuous cardiac output monitoring Salbutamol thalassemia major 226, 1340c, reply l3le, 166 in mechanically ventilated COPD pa 1341¢ Pulmonary blood volume tients 1206e, 1215 »ptic shock (see also sepsis and SIRS) vascular reactivity of the lung vs. nitric oxide in RSV bronchiolitis 81 effects of dobutamine and dopexamine Pulmonary edema Scores 94? cardiogenic APACHE II in pancreatitis 146 liver transplantation for Caroli’s disease noninvasive pressure support ventila- customization of a severity model 140e 1017 tion 15, 21 Glasgow Outcome Scale in children 722 Mycobacterium tuberculosis 238¢ noninvasive ventilation le, 21 measurement of performance of ICUs vasopressin 763 malaria 744 418 without documented infection U Sinusitis Tracheostomy in ICI patients 1066 clinical impact of new procedures 326 Ultrasound nosocomial 1037e percutaneous dilatational Doppler for brain death diagnosis Subarachnoid hemorrhage after translaryngeal tracheostomy 639c R99 barbiturate coma 406 bronchoscopy 3e diagnosis of pneumothorax 383 Guillain-Barré-syndrome 143 pneumoperitoneum 1335 thoracentesis 896e, 955, 1029¢c management of cerebral vasospasm tracheal lesions 102 1463 Transesophageal echocardiography V pressure autoregulation ARDS 637c Vancomycin Sucraliate endocarditis and ventricular septal de- clearance during hemofiltration 1291 . upper gastrointestinal bleeding in me fect 236c chanically ventilated patients 118 monitoring of volume status 1212e measurement in acute renal failure Surfactant postpartum myocardial failure 223 129] lung transplantation 862 superior vena cava thrombosis 1331c Vasospasm Systemic inflammatory response syndrome Transjugular intrahepatic portosystemic cerebral shunt (TIPS) subarachnoid hemorrhage (SIRS) abdominal aortic aneurysm repair improvement of renal function in hepa coronary 279 torenal syndrome 51 ventricular arrhythmia 1471c after major surgery 255¢ Transplantation Vasopressin pharmacokinetics of cepfpirome 486 bone marow septic shock 763 whole body hyperthermia 1013 Chaetonium globosum infection Ventilator—associated lung injury liver consensus conference 1444 impact on renal failure 51 pathomechanism 1040e Thalassemia major respiratory burst 612 small tidal volumes 77le Yersinia enterocolitica sepsis 222 0 1340 c, septic shock 1017 Ventilators reply | tirilazad mesylate as antioxidant 616 exhalation valve and respiratory me- Thermal injury lung chanics 799 ARDS 1231 Cl-esterase inhibitor in graft failure Thermodilution 1315 Ww bronchial 211 surfactant replacement 862 Weaning continuous 166 Trauma noninvasive pressure ventilation indocyanine green 12 early enteral nutrition 157 1355e pulmonary artery vs. arterial flail chest and refractory lung atelectasis noninvasive pressure ventilation in non- Thoracentesis 410 rr COPD patients 1374 ultrasound-aided 896e in combination with methamphetamine model for extubation 1077 Thrombocytopenia intoxication 758 screening parameters 581 intracerebral hemorrhage in critically ill procalcitonin 1031¢ Work of breathing patients 63 renal replacement therapy 805 bronchodilators in COPD 1206e Thrombolysis rupture of vertebral artery 1177 comparison of different ventiiators liver rupture after CPR 1032 SOFA score 389 239c, reply 240c Tonometry Troponin different modalities of mechanical venti- alveolar ventilation changes and gastric myocardial injury in sepsis 1165 lation 775e intramucosal pH 269 lumor necrosis factor (TNFa) inspiratory flow waveform 503 influencing factors 249¢ abdominal aortic aneurysm repait intrinsic PEEP 252e Toxic epidermal necrolysis after major surgery 255e proportional assist ventilation 1021 plasma exchange 1307 cardiac arrest and CPR 588 proportional assist vs. pressure support Toxic shock syndrome immunmodulatory therapies in sepsis ventilation in COPD 790 following influenza A infection 335 556e tracheostomy tubes 514